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Neural progenitor cells (NPCs) derived from human induced pluripotent stem cells (iPSCs) are traditionally maintained and
proliferated utilizing two-dimensional (2D) adherent monolayer culture systems. However, NPCs cultured using this system hardly
reflect the intrinsic spatial development of brain tissue. In this study, we determined that culturing iPSC-derived NPCs as three-
dimensional (3D) floating neurospheres resulted in increased expression of the neural progenitor cell (NPC) markers, PAX6 and
NESTIN. Expansion of NPCs in 3D culture methods also resulted in a more homogenous PAX6 expression when compared to 2D
culture methods. Furthermore, the 3D propagation method for NPCs resulted in a significant higher expression of the astrocyte
markers GFAP and aquaporin 4 (AQP4) in the differentiated cells. Thus, our 3D propagation method could constitute a useful tool
to promote NPC homogeneity and also to increase the differentiation potential of iPSC towards astrocytes.
1. Introduction
Neural progenitor cells (NPCs) are self-renewing and mul-
tipotent cells, which are found in the embryonic, fetal, and
adult mammalian central nervous system (CNS). These cells
have the capacity to differentiate into neurons as well as
glia cells [1, 2]. NPCs derived from pluripotent stem cells
(PSCs), including embryonic stem cells (ESCs) and induced
pluripotent stem cells (iPSCs), are an attractive in vitro
model for studying the pathology of CNS disorders, for
drug development and identification of novel drug targets
[3, 4]. Compared with their in vivo counterparts NPCs are
not as limited in regard to their proliferative status and
differentiation capacity into various neural phenotypes in
vitro [5–8].
NPCs are commonly isolated from different regions of
murine and human brain by microdissection and subse-
quently cultured as free-floating aggregates using both classic
and stirred suspension 3D culture system methods [9, 10].
It is common practice in the field of neuroscience and stem
cell research to maintain and proliferate NPCs by using
either two-dimensional (2D) adherent monolayer or three-
dimensional (3D) floating neurosphere culture systems. Cells
derived from the 3D culture system are thought to be
more representative of the spatial cellular environment found
in living organisms, including features of tissue-specific
architecture, mechanical and biochemical cues, and cell-cell
communication [11]. In accordance, neurospheres are widely
accepted and used as in vitro assays to analyze the properties
of NPCs [12]. This spatial integrity is not found in the 2D
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culturing system, which is considered to be themore artificial
culturing technique [11].
A common approach of human NPCs derivation from
iPSC involves neural induction by inhibition of SMAD
signaling by means of two inhibitors (SB431542 and Noggin
or LDN193189), followed by expansion of NPCs and sub-
sequent terminal differentiation into neurons using the 2D
culture system [8, 13, 14]. Yet, in order to model specific
neurodegenerative diseases in vitro it is crucial that the
culture methods display the desired regional and subtype
specificity compared to the affected neurons of the patient.
Consequently, disease modeling in 3D tissue culture systems
has recently been successfully applied in Alzheimer’s disease
[15] and Parkinson’s disease [16, 17] and to study glia cell
differentiation [18, 19].
The human brain is made up of various subtypes of
neurons but also by a substantial amount of glia cells (more
than 50%) [20]. One subtype of glia cells is astrocytes, which
play a complex and an essential role in neural maturation and
homeostasis, including synaptic transmission and informa-
tion processing by neural circuit functions [21]. Both neurons
and glia cells, except for microglia, are derived from radial
glia (RG) cells in the developing brain. RG cells are a NPC
population, which originates from neuroepithelial cells the
neural tube [5, 22]. During neurogenesis, 5/6 of RG cells
divide asymmetrically into early bipolar intermediate pro-
genitor (IP) cells which eventually differentiate into neurons.
The remaining 1/6 of RG cells give rise to astrocyte and
oligodendrocyte progenitor cells [23–25]. The differentiation
from RG cells to early IP cells is accompanied by the loss of
PAX6 expression [23]. Brain lipid-binding protein (BLBP) is
a verified astrocyte progenitor marker, which was detected
by following the expression pattern of brain BLBP in RG
cells [20, 26]. Later, during development BLBP expression
becomes restricted to astrocyte progenitors and downregu-
lated in astrocytes [27]. One of the most commonly used
astrocyte markers is glial fibrillary acidic protein (GFAP),
which is expressed during CNS development and becomes
restricted to astrocytes lineage [20]. Paired box 6 (PAX6) is
an established NPC marker widely expressed in the radial
glia cells and plays a crucial role in maintaining the NPC
population, lineage-commitment, and gliogenesis [28–31].
Another aspect of neuronal differentiation, which may
be a challenge under in vitro conditions, is the extended
time frame (42–84 days) for achieving functional neuronal
maturation [32, 33]. This can be accelerated by coculturing
neurons with astrocytes. This makes astrocyte differentia-
tion protocols highly desirable and needed for the neural
maturation process [34, 35]. One of the main issues is that
differentiation of astrocytes from fetal or adult postmortem
CNS has been proven to be a difficult process with low
efficiencies [36, 37]. Traditional 2D methods to generate
sufficiently pure population of astrocytes derived from iPSCs
and ESCs are on the other hand very time consuming (>180
days) [38]. Consequently, reliable 3D based differentiation
methods, which can potentially enrich and accelerate astro-
cyte differentiation and maturation, would be beneficial in
order to improve coculturing approaches.
In the present study, we describe a potentially efficient 3D
method of astrocyte enrichment from human iPSC-derived
NPCs. The method progresses through an initial phase of
NPC formation with increasing expression of PAX6 and
NESTIN, which are NPC markers. Furthermore, we directly
established a link between the expression of BLBP, PAX6, and
astrocyte differentiation efficiency [27].Ourmethod provides
an NPCs expansion protocol in 3D, which enriches the high
PAX6 expression NPCs from mixed low and high PAX6
expression NPC pool and could be beneficial for astrocyte
differentiation in which the efficiency can be monitored via
GFAP and AQP4 expression.
2. Materials and Methods
2.1. 2D Monolayer Culture of NPCs and Terminal Differ-
entiation. The three human iPSC lines used in this study
were generated by using the Sendai virus (CytoTune-iPS 2.0
Sendai Reprogramming Kit) (Life Technologies, Carlsbad,
California, USA). Three cell lines were investigated in this
study: clone N S5 and N S8 derived from a healthy 34-year-
old male donor and clone RT S11 derived from a 33-year-
old healthy female donor. NPCs cell lines were induced from
each of these human iPSCs by dual inhibition of SMAD
signaling with 10 𝜇M SB431542 (Sigma-Aldrich, St. Louis,
Missouri, USA) and 100 ng/mL Noggin (R&D Systems, Min-
neapolis, Minnesota, USA). NPCs were expanded in neural
maintenance medium and maintained on plates coated with
poly-L-ornithine (Sigma-Aldrich) and laminin (Roche, Indi-
anapolis, Indiana,USA) (POL/L). Terminal differentiation on
POL/L coated plates was initiated using neural differentiation
medium as described in the Media. Total time of terminal
differentiation was 21 days.
2.2. 3D Neurospheres Culture of NPCs and Terminal Differ-
entiation. Monolayer NPCs from all three lines (N S5, N S8,
and RT S11) were dissociated into single cells with Accutase
(Sigma-Aldrich). A total of 1 × 106 cells/mL were plated on
the low attachment dish (Sarstedt, Newton, Massachusetts,
USA) in neural maintenance medium and maintained for 7
days as neurosphere cultures. Neurospheres were visualized
in an inverted microscope under phase contrast mode.Three
representative pictures of neurospheres were taken from 3
independent cultures with an inverted microscope under
phase contrast mode (approximately 100 neurospheres were
counted for each line, 4x magnification; OLYMPUS CKX41,
Tokyo, Japan). Subsequently, the neurospheres were dissoci-
ated into single cells usingAccutase and next seeded on plates
coated with POL/L. Finally, the cells were differentiated for 21
days in neural differentiation medium.
2.3. Media
2.3.1. Neural MaintenanceMedium (NMM). NMM consisted
of a 50/50 mixture of DMEM/F-12 with GlutaMAX (Life
Technologies) and neurobasal medium (Life Technologies).
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This basic media was supplemented with N2 (Life Technolo-
gies), B27 (Life Technologies), 2mM L-Glutamine (Sigma-
Aldrich), 10 ng/mL basic fibroblast growth factor (bFGF)
(Life Technologies), 10 ng/mL epidermal growth factor (EGF)
(Life Technologies), 1x nonessential amino acid (Sigma-
Aldrich), and 50U/mL penicillin/streptomycin (Life Tech-
nologies).
2.3.2. Neural Differentiation Medium (NDM). NDM was
composed of a 50/50mixture ofDMEM/F-12withGlutaMAX
and neurobasal medium. This basic media was supple-
mented with N2, B27, 2mM L-Glutamine, 1x nonessential
amino acid, 0.2mM ascorbic acid (Sigma-Aldrich), 25𝜇M
2-mercaptoethanol (Life Technologies), and 50U/mL peni-
cillin/streptomycin.
2.4. Flow Cytometry. In order to perform flow cytometry
analysis, NPCs harvested from 2D monolayer and 3D neu-
rosphere were dissociated into single-cell suspension with
Accutase. Dissociated cells were fixed with 4% paraformalde-
hyde (PFA) for 20 min at room temperature (RT) and
subsequently permeabilized with 0,2% Triton X-100 for 20
minutes. Cells were stained for 1 hour at RT with Alexa
Fluor 647 mouse anti-NESTIN and PE mouse anti-human
Pax6 antibodies (BD Pharmingen, San Diego, California,
USA). Flow cytometry analysis was performed using a “Flow
Cytometer Cytomics FC 500” (Beckman Coulter, Pasadena,
California, United States). A red solid state laser 635 nm and
an argon laser 488 nmwere used to detect NESTIN and PAX6
expression in NPCs. Subsequently, we set the specific gate to
calculate the proportion of low PAX6 expressing NPCs from
2D and 3D culturing system. Data was analyzed using FlowJo
software (version 7.6.5) from 3 independent cultures.
2.5. Immunocytochemistry (ICC), Imaging, and Quantifica-
tion. To analyze neural markers cells were fixed in 4% PFA
for 20 minutes at RT, washed in phosphate buffered saline
(PBS), and permeabilized with 0.2% Triton X-100 diluted in
PBS for 20 minutes. Afterwards, cells were blocked in 3%
BSA + 0.2% Triton X-100 in PBS for 1 hour at RT. NPCs
were incubated overnight at 4∘C with the following pri-
mary antibodies: rabbit anti-PAX6 (Covance, Princeton, New
Jersey, USA 1 : 250), mouse anti-NESTIN (Merck Millipore,
Temecula, California, USA, 1 : 1000), rabbit anti-Musashi-1
(Merck Millipore, 1 : 400), mouse anti-SOX2 (R&D System,
1 : 100), and mouse anti-KI67 (Santa Cruz, Dallas, Texas,
USA 1 : 800). Neurospheres were incubated overnight at 4∘C
with rabbit anti-PAX6 (Covance, 1 : 250) and mouse anti-
NESTIN (Merck Millipore, 1 : 1000). Differentiated cells were
incubated overnight at 4∘C with mouse anti-MAP2 (Merck
Millipore, 1 : 1000), rabbit anti-beta-III tubulin (Covance,
1 : 1000), mouse anti-beta-III tubulin (Santa Cruz, 1 : 1000),
rabbit anti-AQP4 (Santa Cruz, 1 : 50), and rabbit anti-GFAP
(DAKO, Glostrup, Denmark 1 : 1000). The primary antibod-
ies were detected using the following fluorescence labeled
secondary antibodies: Alexa Fluor 488 donkey anti-rabbit
IgG (H + L), Alexa Fluor 594 donkey anti-mouse IgG (H
+ L), Alexa Fluor 488 donkey anti-mouse IgG (H + L),
and Alexa Fluor 594 donkey anti-rabbit IgG (H + L) (all
from Life Technologies). Finally, the cells were incubated for
20min at RT with 4󸀠,6-diamidino-2-phenylindole (DAPI) at
a final concentration of 0.2 𝜇g/mL diluted in PBS to detect
nuclei counterstaining. Unspecific binding of the secondary
antibodies was excluded by using only secondary antibody
controls. Cells were analyzed under fluorescent microscope
equipped with 3D imaging module (AxioImager system
with ApoTome, Carl Zeiss MicroImaging GmbH, and Jena,
Germany) and controlled by AxioVision 4.8.1 Microscope
software (Carl Zeiss MicroImaging GmbH, Jena, Germany).
The number of proliferative cells (KI67+) was quantified.The
numbers of neurons (TUBB3+) and astrocytes (GFAP+ and
AQP4+) were quantified. Five pictures per coverslip were
acquired from 3 independent cultures (20x magnification).
On average, approximately 300 cells were counted for each
picture.
2.6. Quantitative Real-Time Polymerase Chain Reaction
(qPCR). Total RNAwas isolated from cultured cells using the
RNeasyPlusMini kit (Qiagen, Venlo, Limburg, Netherlands).
Two micrograms of total RNA was transcribed to cDNA
using the SuperScript VILO cDNA Synthesis kit (Life Tech-
nologies) in accordance with themanufacturer’s instructions.
QPCR reactionswere performedusing LightCycler 480 SYBR
Green I (Roche) on a LightCycler 480 real-time PCRmachine
(Roche). In this study, the house-keeping gene GAPDH was
used for data normalization. Samples were collected from
3 independent cultures. Data was analyzed based on 2−ΔΔCt
method [39]. All used primers for qPCR experiments are
summarized in Table 1.
2.7. Statistics. Distribution of neurosphere diameter was
tested using Kolmogorov-Smirnov normality test. A one-way
analysis of variance (ANOVA) with a Tukey post hocmultiple
comparison test was applied to compare the neurosphere
diameter across all studied cell lines at days 4 and 7. Distribu-
tion of relative abundance of mRNA from the different genes
was examined by using D’Agostino and Pearson omnibus
normality test. Student’s 𝑡-test was performed to compare the
difference between groups. Pearson’s correlation tests were
performed to establish the correlation between the following:
(1) the relativemRNA abundance of PAX6 in 3D neurosphere
NPCs and neurosphere diameter at day 7; (2) the relative
mRNA abundance of BLBP and PAX6 in NPCs and GFAP in
differentiated cells over three studied cell lines. Distribution
of proportion of KI67+, low PAX6 expression, TUBB3+,
AQP4+, and GFAP+ cells was tested using Kolmogorov-
Smirnov normality test. One-way ANOVA with a Tukey post
hoc multiple comparison test and Student’s 𝑡-test was per-
formed to compare the difference between groups. A 𝑝 value
below 0.05 was considered significant. Results are reported
as the Mean ± SEM (standard error of the mean). Data was
analyzed using OriginPro Statistical software (version 9).
3. Results
3.1. Schematic Work Flow of 2D Monolayer Expansion, 3D
Neurosphere Aggregation, and Terminal Differentiation of
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Table 1: Human specific primers used for qPCR analysis.
Symbol Sequence 5󸀠-3󸀠 Productsize (BP) Gene name
Reference number
(NCBI) Reference
GAPDH GGTCACCAGGGCTGCTTTTAGGATCTCGCTCCTGGAAGATG 195
Glyceraldehyde-3-
phosphate
dehydrogenase
NM 001289746.1 [40]
NESTIN CTCCAGAAACTCAAGCACCTCCTGATTCTCCTCTTCCA 145 Nestin NM 006617.1 [41]
SOX2 TTCACATGTCCCAGCACTACCAGATCACATGTGTGAGAGGGGCAGTGTGC 80
SRY- (sex determining
region Y-) box 2 NM 003106.3 [42]
PAX6 TGGTATTCTCTCCCCCTCCTTAAGGATGTTGAACGGGCAG 126 Paired box 6 XM 005252958.3 [43]
BLBP GGCTTTGCCACTAGGCAGGTGACCACTTTGTCTCCTTCTTGA 76
Brain lipid-binding
protein XM 005266858.2 [44]
TUBB3 TCCGCTCAGGGGCCTTTGGACGCTCCGCCCCCTCCGTGTAG 108 Tubulin, beta 3 class III NM 001197181.1
TBR2 CACCGCCACCAAACTGAGATCGAACACATTGTAGTGGGCAG 109 Eomesodermin NM 001278182.1 [45]
AQP4 AGCAGTCACAGCGGAATTTCTTCTGTTCCACCCCAGTTGATG 81 Aquaporin 4 XM 011525942.1 [44]
MAP2 AGTTCAGGCCCACTCTCCCTCCGGGAGCCAGAGCTGATTCCCCA 127
Microtubule-associated
protein 2 XM 011511198.1
GFAP AGGTCCATGTGGAGCTTGACGCCATTGCCTCATACTGCGT 82
Glial fibrillary acidic
protein NM 001242376.1 [44]
Human Neural Progenitor Cell Cultures (NPCs). In order
to investigate whether 3D culturing methods can enhance
astrocyte differentiation from NPCs in vitro, we set up a
direct comparison of 2D and 3D NPC expansion methods
(Figure 1).
3.2. 3D Cultured NPCs Form Proliferating Neurospheres
Positive for PAX6 and NESTIN. We assessed the morphology
of day 4 and 7 neurospheres by phase contrast imaging and
their expression of early neural lineage markers (PAX6 and
NESTIN) by immunocytochemistry. Neurosphere size was
evaluated at days 4 and 7.We observed varying sizes of neuro-
spheres within the different cell lines analyzed (Figure 2(a)).
As shown in Figure 2(b), the diameter of neurospheres from
NPC line N S8 (80.82 ± 6.43 𝜇m) was larger than N S5
(74.26 ± 5.45 𝜇m) and RT S11 (65.05 ± 6.18 𝜇m) at day 4.
Even though we observed significant differences amongst
cell lines, all of them were proliferative as neurospheres and
increased in diameter during culturing. At day 7 the diameter
of neurospheres was significantly increased in all lines (N
S5 = 129.46 ± 11.11 𝜇m, N S8 = 168.35 ± 10.38 𝜇m, and
RT S11 = 98.57 ± 8.37 𝜇m; 𝑝 < 0.01) compared to day 4.
One cell line (N S8) showed a significant larger diameter
at day 7 compared to N S5 and RT S11 (𝑝 < 0.01). All
lines analyzed (N S5, N S8, and RT S11) expressed NESTIN
and PAX6 (Figure 2(c)), confirming NPC marker expression
in the neurospheres. Additionally, to assess the proliferation
capacity of NPCs expanded by the 2Dmethod, we stained for
the proliferation marker Ki-67. As shown in Figures 2(d) and
2(e), we observed significantly higher proportion of NPCs in
N S8 which were positive for Ki-67 (KI67) in comparison
to N S5 and RT S11 (𝑝 < 0.01). This result demonstrates
that NPCs maintain the capacity to proliferate in 2D and
3D culturing system. Furthermore, 3D suspension culture
induces the formation of neurospheres with the expression
of NPC markers.
3.3. Comparison of NPC Markers Expression in 2D and 3D
Cultures. ICCwas performed to examine the expression level
of NPC markers (PAX6, NESTIN, Musashi-1, and SOX2)
in 2D and 3D NPCs. Both were dissociated and plated as
single cells on day 7. As expected, 2D and 3D NPCs were
positive for NESTIN and PAX6 expression (Figure 3(a)).
Furthermore ICC was performed using SRY- (sex determin-
ing region Y-) box 2 (SOX2) and Musashi RNA-binding
protein 1 (Musashi-1), which label self-renewing NPCs in
the nucleus (SOX2) and cytoplasm (Musashi-1) (Figure 3(b)).
Interestingly, PAX6 expressionwas heterogeneous in 2DNPC
cultures. Some areas showed low PAX6 expression (encircled
with dashed line), whilst other areas showed high PAX6
expression (arrows) (Figure 3(a)). In contrast the expression
pattern of PAX6 in 3D dissociated and plated NPCs wasmore
uniformly distributed (Figure 3(a)). Our results show that
NPCs cultured in both 2D and 3D culture system express
NPC markers.
3.4. NPCs in 3D Neurospheres Showed Increased Homogenous
PAX6 Expression. Flow cytometry was implemented to study
the expression level of PAX6 and NESTIN in 2D and
3D NPCs. The intensity of the PAX6 signal in the FACS
analyses revealed two apparently divergent populations in 2D
NPCs whilst 3D NPCs showed only one distinct population.
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Day 7
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into single cells for differentiation
Day 7
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Day 28Day 0
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human NPCs (2D monolayer)
into single cells for differentiation
POL/L
Figure 1: Schematic work flow of 2D monolayer expansion, 3D neurosphere aggregation, and terminal differentiation of human neural
progenitor cell cultures (NPCs). POL/L (poly-L-ornithine/laminin coated plates); NPCs were dissociated into single cells and expanded in
2D monolayers or as 3D neurospheres. They were cultured in the NMM supplemented with growth factors bFGF and EGF for 7 days of
expansion. Afterwards, NPCs from both culturing systems were dissociated into single cells and plated on POL/L coated plates for 21 days of
terminal differentiation.
The appearance of two individual populations was most
prominent with the 2DNS8 cells (Figure 4(a)). Subsequently,
specific gating was applied to compare the proportion of low
PAX6 expression NPCs in 2D and 3D culturing system. Our
results presented in Figure 4(b) show significant decrease
of low PAX6 expression NPCs in 3D culturing system. We
further analyzed all cell lines used for the two culture systems
by qPCR to investigate the expression ofNPCmarkers (SOX2,
PAX6, and NESTIN). The abundance of PAX6 and NESTIN
was significantly increased (𝑝 < 0.01) in 3D cultured NPCs
in comparison with 2D cultured NPCs in all investigated
cell lines (Figure 4(c)). However, we were not able to detect
similar expression tendencies for SOX2 using the 3D culture
system. Pearson’s correlation was used to evaluate the rela-
tionship between the NPC marker PAX6 and neurosphere
diameter. Day 7 neurosphere diameter had strongly positive
(Pearson’s 𝑟 = 0.68, 𝑝 = 0.043) correlation with mRNA
abundance of PAX6 in 3D cultured NPCs (Figure 4(d)).
This indicates a direct correlation between PAX6 expression
and neurosphere diameter. Taken together, we observe that
within the 3D culturing system NPCs displaying low PAX6
expression become eliminated and subsequentlyNPCmarker
expression (PAX6 and NESTIN) is increased.
3.5. Neurosphere Aggregation Promotes Astrocyte Differentia-
tion. The 2D and 3D NPCs were dissociated and differenti-
ated on POL/L plates for 21 days. ICC analysis showed that
the majority of cells derived from NPCs cultured in the two
different systemswere positive for neuronalmarkers (tubulin,
beta 3 class III (TUBB3), and microtubule-associated protein
2 (MAP2); Figures 5(a) and 5(b)). A subset of cells was posi-
tive for GFAP expression, specific for astrocytes, and showed
that the proportion ofGFAPpositive cells was higher inNPCs
derived from 3D versus 2D cultures, primarily observed in N
S5 andRTS11 lines (𝑝 < 0.01) (Figure 5(c)).We also evaluated
the abundance of neuronal and astrocyte marker expression
via qPCR in cells derived from 2D and 3D NPCs, which have
been differentiated for 21 days. At this time point a subset of
3D derived cells expressed higher levels ofGFAP compared to
2D derived cells (Figure 5(d)). Subsequently, to confirm that
3D culture system promotes astrocyte differentiationwe eval-
uate the expression of another astrocyte marker aquaporin 4
(AQP4). As shown in Figures 6(a) and 6(b), significant higher
proportion of AQP4 positive cells were observed in cells
differentiated from 3D cultured NPCs (𝑝 < 0.01). Further-
more, qPCR was performed to verify the ICC quantification
results. Significantly higher expression ofAQP4was observed
in cells differentiated from 3D culturingmethod (Figure 6(c))
(𝑝 < 0.01). Together these data indicate that neurosphere
aggregation could promote astrocyte differentiation. Similar
expression patterns ofMAP2 and TUBB3 and the population
of TUBB3 positive neurons were detected in neurons derived
from NPCs using both culture systems (Figures 5(c) and
5(d)). This implies that there is no apparent difference in
neuronal maturation between the two methods. The correla-
tion between the relative expression abundance of BLBP and
PAX6 in NPCs and GFAP in 21-day differentiated cells was
evaluated using the Pearson correlation analysis (Figures 5(e)
and 5(f)). Pearson correlation analysis demonstrated that the
expression of astrocyte progenitor marker BLBP and NPC
marker PAX6 during NPCs stage has a significant positive
correlation (𝑟 = 0.738, 𝑝 = 4.59 × 10−4 and 𝑟 = 0.703, 𝑝 =
1.12 × 10−3) to the expression of astrocyte marker (GFAP) in
the astrocytes derived from all studied NPCs lines.Therefore,
BLBP and PAX6 expression during NPC stages can be used
as an indicator for potential differentiation into the astrocyte
lineage as verified by GFAP expression. Furthermore, we
performed qPCR analysis to prove that the increase of PAX6
expression and the promotion of astrocyte differentiation
were due to the loss of cells with low PAX6 expression during
neurosphere formation. These low PAX6 expressing cells are
considered early IP cells. Our qPCR results demonstrated a
significant decrease of expression of the IP cell marker eome-
sodermin (TBR2) in cells differentiated from 3D cultured
NPCs compared to 2D cultured NPCs (Figure 6(c)) (𝑝 <
0.01). Herein it can be concluded that the 3D culture method
might promote the astrocytes differentiation and provoke an
inhibition of the IP cells generation.
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Figure 2: 3D culturedNPCs form proliferating neurospheres positive for PAX6 andNESTIN. (a) Phase contrast images of neurospheres from
all 3 lines (N S5, N S8, and RT S11) on day 4 and day 7. Scale bar = 100𝜇m. (b) Analyses of neurosphere diameter on day 4 and day 7 of 3D
suspension culture. Significant difference was tested via one-way ANOVA analysis with a Tukey post hocmultiple comparison test. Significant
differences were indicated as follows: ∗𝑝 < 0.05 and ∗∗𝑝 < 0.01. Results were reported asMean ± SEM of 9 fields from 3 independent cultures.
(c) ICC staining of neurospheres (NESTIN, red, and PAX6, green) on day 7 from all 3 lines. Scale bar = 100 𝜇m. (d) Representative ICC of 2D
NPCs (KI67). Scale bar = 100 𝜇m. (e) Quantification of KI67+ NPCs for 2D culturing systems. Results were reported as Mean ± SEM of 15
fields from 3 independent cultures, tested for significant differences (∗∗𝑝 < 0.01) via one-way ANOVA analysis with a Tukey post hocmultiple
comparison test.
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Figure 3: Comparison of NPCmarkers expression in 2D and 3D cultures. Both 2D and 3DNPCs were dissociated into single cells and plated
onto POL/L coated coverslips. (a) Representative ICC of 2D NPCs and 3D NPCs (PAX6 and NESTIN). Scale bar = 100𝜇m. (b) ICC of 2D
NPCs and 3D NPCs (Musashi-1 and SOX2). Scale bar = 100 𝜇m.
4. Discussion
The present study describes the fate and cellular properties
of human NPCs derived from human iPSC and cultured
as monolayers (2D) and neurospheres (3D). Human NPCs
derived from iPSCs have traditionally been maintained and
proliferated in 2D culture system, demonstrating an efficient
differentiation into the neuronal lineage [13, 14]. However, the
2D culture systems are poor in recapitulating the spatially
well-organized intercellular relationships characteristic of
neural in vivo development in the CNS. In contrast, the
neurospheres generated from 3D free-floating aggregates of
NPCs with a certain spatial degree of complexity better
mimic the main features of brain tissue and can therefore be
considered as more relevant in vitromodels [46]. Thus, neu-
rospheres as a mean to produce neurons and astrocytes could
provide a reliable in vitro cellular model for understanding
CNS disorders and can play a relevant role in cell-based drug
screening [11, 15, 17]. Previously, other groups have described
the generation of neurospheres from brain-derived NPCs
[47, 48]. We have employed the same method to generate
neurospheres from iPSC-derived NPCs making the method-
ologymuchmore versatile for implementation for in vitro cell
modeling. Our findings show that the neurosphere diameter
increases from day 4 to day 7, which indicates the ability of
cell proliferation within the 3D culture system. Further, ICC
characterization showed a very uniform expression of NPC
markers in neurospheres, such as PAX6 and NESTIN. We
alsomonitored the proliferation capacity of 2DNPCs via ICC
for KI67 and observed a higher proportion of KI67 positive
cells in N S8 compared to N S5 and RT S11. The proliferative
capacity of 2D NPCs is directly correlated to the size of the
neurospheres in the 3D system.Therefore, highly proliferative
lines in the 2D system generate larger neurospheres in the 3D
system. It might be that these neurospheres are proliferative
NPCs, similar to brain-derived NPCs.
In the present study, we further compared the NPC
identity and differentiation ability of NPCs cultured in 2D
and 3D culturing systems. We chose PAX6, NESTIN, SOX2,
andMusashi-1 (NPCmarkers) to evaluate the neural identity
of our 2D and 3D NPCs. PAX6 is uniformly expressed in
early neural ectoderm cells of human fetuses and in NPCs
differentiated from human ESCs [49]. Pan-neuronal markers
(SOX2, NESTIN, and Musashi-1) are widely expressed in all
NPCs [50–53]. Some groups also found that PAX6, NESTIN,
and SOX2 are expressed in iPSC-derived NPCs [8, 13, 54].
Moreover, PAX6, NESTIN, SOX2, and Musashi-1 are also
the RG cell markers [55, 56]. Our results demonstrated that
both 2D and 3D NPCs expressed these NPC markers, but
PAX6 andNESTIN expression levels were significantly higher
in 3D NPCs. This indicates that neurosphere aggregation
promotes PAX6 and NESTIN expression. Furthermore, a
more homogenous PAX6 expression was detected in 3DNPC
populations suggesting that an uneven distributed PAX6
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Figure 4: NPCs in 3D neurospheres have increased homogenous PAX6 expression. (a) Flow cytometer dot plot demonstrated that PAX6
expression in 3D NPCs was more homogeneous compared to 2D NPCs. (b) Specific gating was applied to quantify the low PAX6 expression
population in 2D NPCs and 3D NPCs. Student’s 𝑡-test (∗𝑝 < 0.05 and ∗∗𝑝 < 0.01). The bars represent the Mean ± SEM of 3 independent
cultures set. (c) QPCR analysis of SOX2, NESTIN, and PAX6 expression of cultured 2D NPCs and 3D NPCs. Expression values were
normalized to GAPDH (reference gene). Subsequently, the expression values were calculated as relative amount of mRNA versus expression
values of N S5 (monolayer) which was set to 1. Test for significant difference (∗∗𝑝 < 0.01) using Student’s 𝑡-test. The bars represent the Mean
± SEM of 3 independent cultures set. (d) A scatter plot and trend line (Pearson correlation) showed correlation between day 7 neurosphere
diameter and the average relative amount of mRNA of PAX6 in 3D NPCs.
expression pattern in 2D NPCs was avoided by neurospheres
aggregation. PAX6 is an establishedNPCmarker expressed in
RG cells which plays an essential role inmaintaining theNPC
population, neuronal and glial differentiation [29]. Previous
study has shown that neurospheres are largely composed of
RG cells (high PAX6 expression) other than early IP cells
(low PAX6 expression) [57]. As a consequence NPC with
low expression levels of PAX6 cannot form neurospheres.
Consistent with this study, our results indicate that we
could enrich the high PAX6 expression cells from mixed
low and high PAX6 expression NPCs pool by using 3D
culturing method. Furthermore, expression of PAX6 induces
production of larger neurospheres [58]. Consistent with this
study, our results showed that expression of PAX6 in 3D
NPCs was positively correlated to subsequent neurosphere
diameters at day 7.
Herein, we demonstrated that human iPSC-derived
NPCs cultured under 2D and 3D conditions differentiated
into cells positive for mature neuronal markers (MAP2 and
TUBB3) and the astrocyte markers (GFAP and AQP4). The
overall process of directing differentiation of human iPSCs-
derived NPCs to neurons and astrocytes in vitro has been
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Figure 5: Neurosphere aggregation promotes astrocyte differentiation. (a) ICC of 21-day differentiated neurons and astrocytes (TUBB3 and
GFAP) derived from2Dand 3DNPCs. (b) ICCof 21-day neurons (MAP2 andTUBB3) differentiated from2Dand 3DNPCs. (c)Quantification
of TUBB3+ and GFAP+ cells from iPSC-derived NPCs. Results were reported as Mean ± SEM of 15 fields from 3 independent cultures, tested
for significant difference (∗𝑝 < 0.05 and ∗∗𝑝 < 0.01) using Student’s 𝑡-test. (d) Gene expression by qPCR analysis of TUBB3, MAP2, and
GFAP. The expression values were normalized to GAPDH. Subsequently, the expression values were calculated as relative amount of mRNA
versus expression values of N S5 (derived from 2D NPCs) 21-day differentiated cells, which was set to 1. Data was reported as Mean ± SEM
of 3 independent cultures, tested for significant difference (∗𝑝 < 0.05 and ∗∗𝑝 < 0.01) using Student’s 𝑡-test. (e) A scatter plot and trend
line (Pearson correlation) showed correlation between the average relative amount of GFAP (21-day differentiated cells) and BLBP (NPCs)
mRNA. The expression values of BLBP in NPCs were calculated as relative amount of mRNA versus expression values of N S5 (monolayer)
which was set to 1. Data was obtained from 3 independent cultures. (f) A scatter plot and trend line (Pearson correlation) showed correlation
between the average relative amount of GFAP (21-day differentiated cells) and PAX6 (NPCs) mRNA.
described earlier [59]. As a novel finding, our experiments
demonstrated that propagation under the 3D conditions
resulted in a significantly higher yield of cells withGFAP and
AQP4 expression compared to the 2D condition. Hence, we
draw a conclusion that 3DNPCs culturingmethods stimulate
astrocyte differentiation. This observation is in agreement
with previously described findings, which show efficient
3D differentiation of ESC-derived NPCs to glial cells of
the peripheral nervous system, in particular Schwann cells
[18].Moreover, we demonstrated that theGFAP expression in
astrocytes was significantly positively correlated to the astro-
cyte progenitor marker BLBP expression in NPCs, which is
in accordance with observations of other groups [20, 26, 27].
Furthermore, it has been shown that abolishing the expres-
sion of PAX6 leads to the downregulation of GFAP expres-
sion, resulting in inhibition of astrocyte maturation [30, 60].
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Figure 6: Increased astrocyte differentiation mediated by neurospheres. (a) ICC of 21-day differentiated astrocytes (AQP4) derived from 2D
and 3D NPCs. (b) Quantification of AQP4+ positive astrocytes derived from 2D and 3D NPCs. Results were reported as Mean ± SEM of
15 fields from 3 independent cultures (∗∗𝑝 < 0.01), using Student’s 𝑡-test. (c) Analysis of gene expression by qPCR of AQP4 and TBR2. The
expression values were normalized to GAPDH gene expression. Subsequently, the expression values were calculated as relative amount of
mRNA versus expression values of N S5 (derived from 2D NPCs) 21-day differentiated cells, which was set to 1. Data was reported as Mean ±
SEM of 3 independent cultures, tested for significant difference (∗∗𝑝 < 0.01) using Student’s 𝑡-test.
Similar to these studies, we found that theGFAP expression in
astrocytes was strongly and positively associated with PAX6
expression pattern during the NPC stage. These correlation
studies underline the importance of BLBP and PAX6 expres-
sion in NPCs for differentiation towards an astrocyte fate.
Single-cell mRNA profiling indicates that neurospheres
are composed of RG cells (high PAX6 expression) other than
early IP cells or IP cells (low PAX6 expression) [57]. Similar to
this study, we observed that there was a significant decrease
of expression of the IP cell marker TBR2 in the differentiated
Stem Cells International 13
cells derived from 3D NPCs when compared to 2D NPCs.
This indicated that neurosphere formation is associated with
the loss of early IP cells (low PAX6 expression cells), resulting
in the decrease of TBR2 expression in differentiated cells.
During neurogenesis, IP cells asymmetrically divide into
neurons and IP daughter cells [25]. Moreover, 1/6 of RG cells
(high PAX6 expression cells) proceed to produce astrocyte
and oligodendrocyte progenitors, resulting in the generation
of astrocytes and oligodendrocytes [24, 25]. However, we do
not observe the suppression of neuronal differentiation in
our 2D analyzed cell lines. The reason for this may be due
to the fact that only a small population of RG cells would
proceed to give rise to glia cells; the remaining RG cells are
still able to differentiate into neurons. Taken together, our
results demonstrate that astrocyte differentiation is promoted
by 3D propagation and relies on the increase of neurosphere
aggregation.
5. Conclusion
In summary, we established a reliable NPC culture system
in 3D that efficiently enriches GFAP and AQP4 positive
astrocytes during terminal differentiation. Propagation of
NPCs using the 3D culture system promotes the expression
of RG cell markers (PAX6 andNESTIN). Subsequently,GFAP
and AQP4 expression is increased during terminal astrocyte
differentiation in the cells differentiated from 3D cultured
NPCs.These results revealed an attractivemethod to improve
the astrocyte differentiation ability from iPSC-derived NPCs
in a shorter time frame and with higher efficiency compared
to derivations from 2D cultured NPCs.
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